SCHEMBL21889534

SCHEMBL21889534

C[Si](C)(C)CCOCn1nc(CC2CCCC2)nc1-c1ccc(O)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 5/20 0.35
NPC1 O15118 1/20 0.34
LMNA P02545 1/20 0.34
TP53 P04637 1/20 0.34
MAPK1 P28482 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
HTR6 P50406 1/20 0.31
PDE4D Q08499 1/20 0.31
PDE7A Q13946 1/20 0.31
ADORA3 P0DMS8 1/20 0.31
ADORA2A P29274 1/20 0.31
ADORA2B P29275 1/20 0.31
ADORA1 P30542 1/20 0.31
SIGMAR1 Q99720 2/20 0.31
TMEM97 Q5BJF2 1/20 0.31
KLKB1 P03952 1/20 0.31
MIF P14174 1/20 0.30
USP7 Q93009 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21889537 0.84 DGAT1 (0.43) DGAT1SMN1; SMN2
SCHEMBL21914802 0.82 DGAT1 (0.36) DGAT1PDE4DPDE7AADORA3ADORA2A
SCHEMBL21889297 0.80 DGAT1 (0.36) DGAT1PDE4DPDE7AKLKB1USP7
SCHEMBL21889200 0.80 AOC3 (0.37) DGAT1PDE4DPDE7AKLKB1USP7
SCHEMBL21889307 0.79 AOC3 (0.39) DGAT1SIGMAR1TMEM97KLKB1
SCHEMBL21889523 0.76 DGAT1 (0.35) DGAT1HTR6KLKB1USP7
SCHEMBL21889841 0.76 DGAT1 (0.34) DGAT1KLKB1USP7
SCHEMBL16661224 0.74 DGAT1 (0.42) DGAT1NPC1RAB9A
SCHEMBL21914812 0.74 AOC3 (0.35) DGAT1
SCHEMBL21889839 0.73 AOC3 (0.45) DGAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3626699-B1 SSAO INHIBITOR SHANDONG DANHONG PHARMACEUTICAL CO LTD (CN) 2023-07-12 EP disclosed
US-20210198220-A1 SSAO INHIBITOR SHANDONG DANHONG PHARMACEUTICAL CO LTD (CN) 2021-07-01 US disclosed
US-11001563-B2 SSAO inhibitor SHANDONG DANHONG PHARMACEUTICAL CO LTD (CN) 2021-05-11 US disclosed
US-20200115352-A1 SSAO INHIBITOR SHANDONG DANHONG PHARMACEUTICAL CO., LTD. 2020-04-16 US disclosed
EP-3626699-A1 SSAO INHIBITOR Shandong Danhong Pharmaceutical Co., Ltd. (CN) 2020-03-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11001563-B2 SSAO inhibitor SSB, ASAH2, AOX1 DGAT1 3115/4885NPC1 567/4885LMNA 3248/4885
US-20210198220-A1 SSAO INHIBITOR SSB, ASAH2, AOX1 DGAT1 3115/4885NPC1 567/4885LMNA 3248/4885
US-20200115352-A1 SSAO INHIBITOR SSB, ASAH2, AOX1 DGAT1 3115/4885NPC1 567/4885LMNA 3248/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.